Business Description
Raphael Pharmaceutical Inc
NAICS : 325411
SIC : 2833
ISIN : US27785B2088
Description
Raphael Pharmaceutical Inc is a pharmaceutical drug research and development company focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol, or CBD oil.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -12.08 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -18.2 | |||||
| 3-Year EPS without NRI Growth Rate | -14.5 | |||||
| 3-Year FCF Growth Rate | -12.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 0.12 | |||||
| 6-1 Month Momentum % | -83.12 | |||||
| 12-1 Month Momentum % | -56.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.07 | |||||
| Quick Ratio | 0.07 | |||||
| Cash Ratio | 0.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.1 | |||||
| Shareholder Yield % | -6.15 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -393.25 | |||||
| ROIC % | -10900 | |||||
| ROC (Joel Greenblatt) % | -49050 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -4.92 | |||||
| EV-to-EBITDA | -4.92 | |||||
| EV-to-FCF | -8.63 | |||||
| Earnings Yield (Greenblatt) % | -20.33 | |||||
| FCF Yield % | -11.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RAPH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Raphael Pharmaceutical Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.03 | ||
| Beta | 0 | ||
| Volatility % | 110.34 | ||
| 14-Day RSI | 0.12 | ||
| 14-Day ATR ($) | 0.014802 | ||
| 20-Day SMA ($) | 0.26 | ||
| 12-1 Month Momentum % | -56.67 | ||
| 52-Week Range ($) | 0.23 - 1.65 | ||
| Shares Outstanding (Mil) | 18.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Raphael Pharmaceutical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Raphael Pharmaceutical Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Raphael Pharmaceutical Inc Frequently Asked Questions
What is Raphael Pharmaceutical Inc(RAPH)'s stock price today?
The current price of RAPH is $0.26. The 52 week high of RAPH is $1.65 and 52 week low is $0.23.
When is next earnings date of Raphael Pharmaceutical Inc(RAPH)?
The next earnings date of Raphael Pharmaceutical Inc(RAPH) is .
Does Raphael Pharmaceutical Inc(RAPH) pay dividends? If so, how much?
Raphael Pharmaceutical Inc(RAPH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers